Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

NSS Labs Initiates Group Test Coverage of the Endpoint Detection and Response Market

Posted on: 13 Mar 18

AUSTIN, Texas, March 13, 2018 (GLOBE NEWSWIRE) -- NSS Labs, Inc., a global leader and trusted source for independent, fact-based cybersecurity guidance, today announced that it is expanding on its strong foundation of point-in-time testing and continuous security validation with the introduction of the Endpoint Detection and Response (EDR) Group Test. As part of today’s announcement, the company is also issuing a call for industry engagement for both enterprises and EDR vendors to help shape and evolve its upcoming EDR group test and accompanying methodology. 

EDR products provide enhanced detection, response, and forensic capabilities, but they do not provide the automated blocking capabilities offered by advanced endpoint protection (AEP) products. EDR products detect known threats in real time and for unknown threats, they enable effective incident response based on correlated actions, intelligence, or analytics. Their continuous monitoring and analysis capabilities allow them to cross-correlate data within an environment and assist in post-incident remediation.

EDR products offer comprehensive end-to-end visibility into threats, allowing security professionals to discover, investigate, and respond to previously unidentified attacks across an enterprise. EDR products offer forensic insights that can accelerate incident response and address data gaps that often exist in endpoint protection technologies. For this reason, they focus less on how security controls were bypassed and more on a threat’s behavior and identification of potential data loss.

The EDR market is evolving quickly as vendors work to secure endpoints against an equally fast-moving threat landscape. Industry analysts predict that the EDR market will grow to $1.5 billion by 2020 with a CAGR of 45.3%.1 According to an NSS Labs study, 93.6% of US enterprises currently deploy endpoint security products; of those, 18.4% currently deploy stand-alone EDR products.

“Enterprises are increasingly seeking endpoint security tools that focus on identifying adversaries’ objectives, surfacing their tactics, techniques, and procedures, and ultimately containing or remediating adversaries,” said Jason Brvenik, Chief Technology Officer at NSS Labs. “We believe that our EDR group test will provide valuable insights regarding the overall effectiveness and capabilities of the EDR products in the market today. We encourage and invite enterprises and vendors to collaborate with us regarding the use cases for EDR products and our test methodology to help highlight the strengths and differentiation within the market.”

NSS Labs has a long history in testing enterprise-class security products. NSS Labs’ rigorous, independent group tests offer independent analysis of the top security technologies used today by Global 2000 companies. They provide the industry’s most comprehensive review of security effectiveness, performance, and total cost of ownership, which enterprises use to inform their decision-making. Enterprises rely on NSS Labs group tests for fact-based, empirical data which they can use to evolve their security architectures. Within the last 12 months, NSS Labs has released group test results for several categories of mature and evolving cybersecurity products. To learn more about our group tests, visit the NSS Labs website.

Enterprises that wish to provide feedback regarding NSS Labs’ upcoming EDR Group Test and its associated test methodology can send feedback to Vendors can send feedback to

Additional Resources: 

1. Gartner “Morphing EDR Market Grows to 1.5 Billion in 2020, March 2017

About NSS Labs, Inc.
NSS Labs, Inc. is recognized globally as the most trusted source for independent, fact-based cybersecurity guidance. Our mission is to advance transparency and accountability within the cybersecurity industry. We empower enterprises by providing them with timely, relevant information on which to base their decisions. Our unmatched foundation in security testing, along with our extensive research and global threat analysis capabilities, provide the basis for our CAWS Continuous Security Validation Platform. CAWS measures the ongoing effectiveness of security controls, providing a real-time score card to help business leaders substantiate their security investments. Businesses can also leverage the threat data delivered by CAWS to strengthen their cyber risk posture and mitigate threats to their operating systems and applications. CISOs, Chief Security Architects, SOC and Threat Analysts, and information security professionals from many of the world's largest and most demanding enterprises rely on trusted insights from NSS Labs. For more information, visit

Tom Resau
W2 Communications
Phone: +1 703-877-8103


Last updated on: 13/03/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.